Home  /  Resource Library  /  Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkins Lymphoma

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkins Lymphoma

Long term follow up of a study investigating brentuximab vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma. (Abstract only)